The temporary halt to investigate reported neurovascular events comes two months after Johnson & Johnson won FDA approval for ...

The Irvine, California-based company makes an insulin pump called the iLet Bionic Pancreas, which was cleared by the Food and ...

The document follows the agency’s first digital health advisory meeting and a final guidance on postmarket updates to AI ...

Stryker made several small deals last year but lacked a larger acquisition like its nearly $5 billion proposal for Inari ...

Stifel analyst Rick Wise said the financing, a combination of private stock placement and new loans, should help the dialysis ...

The agency issued the alert as part of a pilot to improve the timeliness of communications about actions it believes are ...

The FDA released the guidance in response to concerns that the devices are less accurate in people with darker skin ...

McKinsey data shows that over a 10-year period, supply chain shocks could cost a medical device company 38% of a typical year ...

Olympus advised providers to stop using an endoscope accessory due to an infection risk linked to 120 injuries and one death.

Kolaleh Eskandanian, chief innovation officer at Children’s National Hospital, said the partnership is meant to address the ...

Officials commissioned the independent review in September in response to a study that found tampons may expose users to ...

Multibillion-dollar buyouts returned last year, led by Johnson & Johnson’s $13.1 billion acquisition of Shockwave Medical.